Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...

Randomization Techniques (60 minutes): In this workshop, the rationale behind randomized experiments will be explained. Descriptions of commonly utilized randomization algorithms will be presented, ...

Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...

Randomised clinical trials (RCTs) remain the gold standard in evaluating therapeutic interventions, ensuring that treatment effects are not confounded by systematic errors. Central to these trials is ...

Minimal residual disease (MRD) refers to the small number of myeloma cells that may remain after treatment and are not detectable using conventional response criteria. In multiple myeloma, MRD ...

The S2302 Pragmatica-Lung trial, led by the SWOG and run through the National Cancer Institute's National Clinical Trials Network, is a pragmatic registrational-intent study for advanced non–small ...

The pharmaceutical industry has evolved significantly in the past few decades to better meet the needs of today’s patients. Since I left my medical practice to join the industry 15 years ago, the role ...

Immunocore (IMCR) announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous ...

Fondazione Ricerca e Innovazione Cardiovascolare ETS (Fondazione RIC), a leading independent non-profit research foundation at the forefront of cardiovascular innovation, in collaboration with ...

(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 18 June 2024) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company ...